Lopinavir/ritonavir maintenance monotherapy after successful viral suppression with standard highly active antiretroviral therapy in HIV-1-infected patients

被引：29

作者：

Campo, RE ^{[1
]}

Lalanne, R

Tanner, TJ

Jayaweera, DT

Rodriguez, AE

Fontaine, L

Kolber, MA

机构：

[1] Univ Miami, Sch Med, Div Infect Dis, Miami, FL USA

[2] Abbott Labs, Abbott Pk, IL 60064 USA

来源：

AIDS | 2005年 / 19卷 / 04期

关键词：

D O I：

10.1097/01.aids.0000161777.38438.ed

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：447 / 449

页数：3

共 15 条

[1]

ARRIBAS JR, 2004, 15 INT AIDS C BANGK

[2] Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients [J].

Benson, CA ;

Deeks, SG ;

Brun, SC ;

Gulick, RM ;

Eron, JJ ;

Kessler, HA ;

Murphy, RL ;

Hicks, C ;

King, M ;

Wheeler, D ;

Feinberg, J ;

Stryker, R ;

Sax, PE ;

Riddler, S ;

Thompson, M ;

Real, K ;

Hsu, A ;

Kempf, D ;

Japour, AJ ;

Sun, E .

JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (05) :599-607

[3] Drug resistance and predicted virologic responses to human immunodeficiency virus type 1 protease inhibitor therapy [J].

Condra, JH ;

Petropoulos, CJ ;

Ziermann, R ;

Schleif, WA ;

Shivaprakash, M ;

Emini, EA .

JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (03) :758-765

[4] Guidelines for using antiretroviral agents among HIV-infected adults and adolescents - The panel on clinical practices for treatment of HIV [J].

Dybul, M ;

Fauci, AS ;

Bartlett, JG ;

Kaplan, JE ;

Pau, AK .

ANNALS OF INTERNAL MEDICINE, 2002, 137 (05) :381-433

[5] Final analysis of the Trilege induction-maintenance trial: results at 18 months [J].

Flandre, P ;

Raffi, F ;

Descamps, D ;

Calvez, V ;

Peytavin, G ;

Meiffredy, V ;

Harel, M ;

Hazebrouck, S ;

Pialoux, G ;

Aboulker, JP ;

Vezinet, FB .

AIDS, 2002, 16 (04) :561-568

[6]

GATHE JC, 2004, 15 INT AIDS C BANGK

[7] Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy [J].

Gulick, RM ;

Mellors, JW ;

Havlir, D ;

Eron, JJ ;

Gonzalez, C ;

McMahon, D ;

Richman, DD ;

Valentine, FT ;

Jonas, L ;

Meibohm, A ;

Emini, EA ;

Chodakewitz, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) :734-739

[8] Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy [J].

Havlir, DV ;

Marschner, IC ;

Hirsch, MS ;

Collier, AC ;

Tebas, P ;

Bassett, RL ;

Ioannidis, JPA ;

Holohan, MK ;

Leavitt, R ;

Boone, G ;

Richman, DD .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (18) :1261-1268

[9] Ritonavir boosted indinavir treatment as a simplified maintenance 'mono'-therapy for HIV infection [J].

Kahlert, C ;

Hupfer, M ;

Wagels, T ;

Bueche, D ;

Fierz, W ;

Walker, UA ;

Vernazza, PL .

AIDS, 2004, 18 (06) :955-957

[10] Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients [J].

Kempf, DJ ;

Isaacson, JD ;

King, MS ;

Brun, SC ;

Xu, Y ;

Real, K ;

Bernstein, BM ;

Japour, AJ ;

Sun, E ;

Rode, RA .

JOURNAL OF VIROLOGY, 2001, 75 (16) :7462-7469

← 1 2 →